Sarcoidosis Clinical Trials
Here are the 6 most popular medical studies for
Cell Free DNA Testing for Myocarditis
Recruiting0 awards14 criteria
Iowa City, Iowa
This trial is looking at a potential new way to diagnose active myocarditis (inflammation of the heart) in patients with sarcoidosis. The current method for diagnosing active myocarditis is limited and this trial is exploring whether cell free DNA (fragments of genomic DNA that are released into the circulation from dying or damaged cells) can be used as a biomarker to more accurately diagnose active myocarditis.
Phosphodiesterase-4 (PDE-4) Inhibitor
Roflumilast for Sarcoidosis
Recruiting4 awardsPhase 4
Cincinnati, Ohio
Pulmonary sarcoidosis patients with fibrosis often develop recurrent episodes of bronchitis. These can lead to worsening of disease for both the short and long term. Roflumilast has been shown to reduce the number of acute bronchitis episodes in patients with COPD. Drugs similar to Roflumilast have been shown to help sarcoidosis. The current study is to determine if Roflumilast will reduce number of episodes of bronchitis and help fibrotic sarcoidosis.
Popular filter options for trials
Sarcoidosis Clinical Trials With No Placebo
View 24 sarcoidosis medical studies that do not have a placebo group.
Diagnostic Test
Enhanced Screening Protocol for Cardiac Sarcoidosis
Recruiting1 award3 criteria
Denver, Colorado
This trial is testing a new protocol to screen for cardiac sarcoidosis. The routine clinical care is to gather patient's history of symptoms and under go an ECG. If a patient has an abnormal results in standard screening, they typically have further evaluations as part of their routine medical care. These tests might include an echocardiogram, ambulatory ECG, and advanced cardiac imaging (MRI, PET scan as per local practice). A patient that has normal results on standard screening will be randomly assigned to enhanced screening at each center. Half the patients will be randomized to usual follow-up (annual symptom assessment and ECG) and
Corticosteroid
Prednisone/Prednisolone Dosing for Cardiac Sarcoidosis
Recruiting4 awardsPhase 3
New Haven, Connecticut
This trial is comparing the effectiveness of two different doses of Prednisone (or Prednisolone), one standard and one low, in patients with cardiac sarcoidosis who have not yet been treated. The Investigators hypothesize that the low dose will be just as effective as the standard dose, but with better quality of life and less toxicity.
View More Trials
See another 6 medical studies focused on .
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.